Ligand Pharmaceuticals
LGND
#4123
Rank
A$3.98 B
Marketcap
A$206.79
Share price
-0.67%
Change (1 day)
24.58%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2025 (TTM): A-$11.06

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$10.91. In 2024 the company made an earnings per share (EPS) of A-$0.07663 a decrease over its 2023 EPS that were of A$4.43.

EPS history for Ligand Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$11.0614327.39%
2024A-$0.07663-101.73%
2023A$4.43-245.96%
2022A-$3.03-157.23%
2021A$5.30-2571.43%
2020A-$0.21-100.46%
2019A$46.92353.48%
2018A$10.351025%
2017A$0.92-700%
2016A-$0.15-100.87%
2015A$17.721859.32%
2014A$0.905.36%
2013A$0.868.0704505322479E+18%
2012A$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
A$16.94-255.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.55-94.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$2.39-121.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$10.57-196.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.13-119.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$18.94-273.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.11-137.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$0.04598-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$13.90-227.35%๐Ÿ‡บ๐Ÿ‡ธ USA